Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial

Fig. 5

A representative case showing a high intersphincteric fistula resulted in Crohn’s disease. A 25-year-old male patient had been diagnosed with an anal fistula in July 2017 and was assigned to observation group. This patient was completely healed at 3 months and complete healing was sustained for up to 12 months after injection. a Preinjection, b 3 months, c 6 months, and d 12 months after injection of ADSCs

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512